European startups
fromAxios
2 weeks agoExclusive: Record funding for fusion power lands as Trump eyes cuts
The Energy Department's ARPA-E will invest $135 million in fusion energy technologies to overcome barriers to commercialization.
British pharmaceutical giant AstraZeneca has pledged a $15 billion investment in China by 2030, aiming to expand its medicines manufacturing and research and development capabilities. The announcement, made on Thursday during Prime Minister Keir Starmer's visit to Beijing, marks the largest deal of his trip as Britain seeks to strengthen ties with China amid strained relations with Washington. Prime Minister Starmer welcomed the investment, stating: "AstraZeneca's expansion and leadership in China will help the British manufacturer continue to grow - supporting thousands of UK jobs."